EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Acetyl Salicylic Acid, COX ‐2 Inhibitors and Other NSAIDs and Breast Cancer Survival in a Finnish Population‐Based Cohort

M Malin iD, M Murto iD, O Arponen, A Jukkola, A Siltari iD, M Artama, K Visvanathan, T Murtola iD

Cancer Reports · 2025

DOI: 10.1002/cnr2.70271 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Reports, 2025. Verfasst von M Malin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Tampere University Faculty of Medicine and Health Technology, Tampere, Finland. Hauptthemen laut MEDLINE: Breast Neoplasms, Aspirin, Anti-Inflammatory Agents, Non-Steroidal, Cyclooxygenase 2 Inhibitors. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pirkanmaa Health Care District.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Non‐steroidal anti‐inflammatory drugs (NSAIDs), particularly acetylsalicylic acid (ASA), have been associated with reduced breast cancer (BCa) mortality. While overexpression of cyclooxygenase‐2 (COX‐2) correlates with poorer prognosis in BCa, COX‐2 inhibitors (coxibs) have not demonstrated a survival advantage. However, the evidence remains conflicting and limited. We examined associations between BCa mortality and NSAID use in a Finnish population‐based cohort.

Methods

The study cohort, 73 170 women with new BCa diagnosis during 1995–2013 was identified from The Finnish Cancer Registry. Follow‐up data including date and the cause of death, NSAID purchases from 1995 to 2015, mammography screening participation and tumor hormone receptor status, were obtained from national registries. NSAID purchases were categorized into NSAIDs overall, ASA, and coxibs. BCa‐specific and overall survival by NSAID use were analyzed using Cox proportional hazard regression, adjusted for age, tumor extent, primary treatment, Charlson comorbidity index, hypertension, diabetes, mammography participation, and hormonal therapy.

Results

Pre‐diagnostic use of NSAIDs (HR 0.78, 95% CI: 0.75–0.81) and coxibs (HR 0.76, 95% CI: 0.71–0.81) was associated with reduced BCa mortality, while ASA showed no association. Post‐diagnostic NSAID use was associated with increased BCa mortality (HR 1.27, 95% CI: 1.22–1.33), while ASA use (HR 0.84, 95% CI: 0.73–0.97) showed dose‐dependent risk reduction.

Conclusion

Post‐diagnostic use of ASA is associated with reduced BCa‐specific mortality, distinguishing ASA from other NSAIDs. Clinical trials are required to determine the ideal ASA dose, frequency, and duration for treating BCa. Pre‐diagnostic use of NSAIDs overall is associated with a slight reduction in BCa mortality without dose dependence. The potential role of pre‐diagnostic NSAID use as a prognostic factor in BCa warrants further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsAspirinAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2 InhibitorsHumansFemaleFinlandMiddle AgedAgedRegistriesPrognosisFollow-Up StudiesAdultCohort Studies

Substanzen

AspirinAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2 Inhibitors

Autor:innen und Institutionen

  • Tampere University Faculty of Medicine and Health Technology, Tampere, Finland.
  • Department of General Surgery, TAYS Cancer Center, Tampere, Finland.
  • Department of Oncology, TAYS Cancer Center, Tampere, Finland.
  • Department of Pharmacology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Department of Health Protection, Finnish Institute for Health and Welfare, Tampere, Finland.
  • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

ORCID-Profile: M Malin, M Murto, A Siltari, T Murtola

Förderung

  • Pirkanmaa Health Care District

Zitieren

APA

Malin, M., Murto, M., Arponen, O., Jukkola, A., Siltari, A., Artama, M., Visvanathan, K., & Murtola, T. (2025). Acetyl Salicylic Acid, COX ‐2 Inhibitors and Other NSAIDs and Breast Cancer Survival in a Finnish Population‐Based Cohort. Cancer Reports. https://doi.org/10.1002/cnr2.70271

Vancouver

Malin M, Murto M, Arponen O, Jukkola A, Siltari A, Artama M, et al. Acetyl Salicylic Acid, COX ‐2 Inhibitors and Other NSAIDs and Breast Cancer Survival in a Finnish Population‐Based Cohort. Cancer Reports. 2025. doi:10.1002/cnr2.70271

BibTeX
@article{Malin2025,
  author = {Malin, M and Murto, M and Arponen, O and Jukkola, A and Siltari, A and Artama, M and Visvanathan, K and Murtola, T},
  title = {Acetyl Salicylic Acid, COX ‐2 Inhibitors and Other NSAIDs and Breast Cancer Survival in a Finnish Population‐Based Cohort},
  journal = {Cancer Reports},
  year = {2025},
  doi = {10.1002/cnr2.70271}
}
Kostenlos starten →